MedTrace Logo

The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing

NCT00110604 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 835

Last updated 2008-12-31

No results posted yet for this study

Summary

The purpose of this study is to determine if folic acid supplementation can slow down atherosclerotic progression, age-related cognitive decline and age-related hearing loss.

Conditions

Interventions

BEHAVIORAL

folic acid (0.8 mg)

Sponsors & Collaborators

  • Wageningen Centre for Food Sciences

    collaborator OTHER

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Wageningen University

    lead OTHER

Principal Investigators

  • Petra Verhoef, PhD · Wageningen Centre for Food Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-09-30
Completion
2004-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00110604 on ClinicalTrials.gov